Pfizer/BioNTech says three doses ‘effective’ against Omicron
FRANKFURT, Dec 8, 2021 (AFP) – The coronavirus vaccine developed jointly by BioNTech and Pfizer is “still effective” against the Omicron variant of the virus after three doses, the companies said in a statement on Wednesday. A laboratory study by its makers found the vaccine “is still effective in preventing Covid-19, also against Omicron, if it … Read more